Phoenix, Arizona--(Newsfile Corp. - February 24, 2020) - The Stock Day Podcast welcomed US Nuclear Corp. (OTCQB: UCLE) ("the Company"), a radiation and chemical detection holding company specializing in the development and manufacturing and sales of radiation and chemical detection instrumentation. CEO of the Company, Robert Goldstein, joined Stock Day host Everett Jolly.
Jolly began the interview by asking about the Company's recently signed stock purchase agreement to acquire 40% of the startup Grapheton Inc. "We're really excited about this," said Goldstein. "It's a startup out of San Diego State University," he explained, adding that Grapheton develops brain stimulation electrodes. "We bought 40% of the company, because we want the inventors to stay on," said Goldstein. "We do intend to acquire the company in full eventually."
"How did you find out about this company?", asked Jolly. Goldstein explained that Grapheton Inc. was looking for a technical partner that could help them move forward with their current projects. "I think this is a pretty perfect match," said Goldstein. He then elaborated on the potential of the type of interface the partnership is looking to develop, which could be beneficial for a significant number of applications.
"Is Grapheton Inc. similar to Elon Musk's new Neuralink company?", asked Jolly. "It is in many ways," explained Goldstein. "Their whole purpose is to have electrodes in the brain to pick up the pulses and information from the neurons themselves and go back with a simulation," said Goldstein. "We're in that same space. They're doing it in more of a massive way to talk to the whole brain at once, we're more specific," he added, noting that the Company is developing applications for diseases and injuries. "This is going to be the brain-machine interface revolution."
Jolly then noted that the Company has been primarily operating in the radiation and chemical detection space, and asked about their decision to get involved with Grapheton Inc. "We look at ourselves not just as a Geiger counter or radiation measurement company, but as a sensor company," said Goldstein. He then explained that Grapheton develops sensors that are able to analyze neuron communications, while also measuring hormones and chemical compositions in the brain.
Goldstein then shared that the brain electrodes developed by Grapheton Inc. have numerous advantages compared to similar technologies on the market. "The biggest difference is that we're using graphene," said Goldstein. "It's electrically conductive, which means we have carbon-based electrodes," he added, noting that many competitors are using metal electrodes which will corrode over time and could become harmful in the brain. "Our electrodes can last as much as forty years," said Goldstein.
Goldstein then shared that Grapheton Inc. also has a patent on a super-capacitor that collects electricity from the brain itself, allowing the brain to operate sensors without the need for batteries.
Jolly then asked about the Company's revenue potential for this project. "I think we will be making major revenues within two years," closed Goldstein, adding that Grapheton Inc. already produces some revenue, but will be undergoing trials and testing as they continue to develop their technology.
To hear Robert Goldstein's entire interview, follow the link to the podcast here:
is a proud sponsor of "Stock Day," and Stock Day Media encourages listeners to visit the company's message board at
About US Nuclear Corp.
US Nuclear Corp is a radiation and chemical detection holding company specializing in the development and manufacturing and sales of radiation and chemical detection instrumentation. Through three operating divisions (Technical Associates (TA), Overhoff Technology (OTC), and Electronic Control Concepts (ECC), US Nuclear Corp. harbors more than 100 years of combined experience in supplying top of the line instrumentation to any industry utilizing radionuclides. This includes nuclear power plants, national laboratories, government agencies, homeland security, military, universities and schools, research companies, hospitals, medical and dental centers, energy companies, weapons facilities, first responders, local governments, and manufacturing plants.
Safe Harbor Act
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.
Investors may find additional information regarding US Nuclear Corp. at the SEC website at , or the company's website at .
CONTACT:
US Nuclear Corp. (UCLE)
Robert I. Goldstein, President, CEO, and Chairman
Rachel Boulds, Chief Financial Officer
(818) 883 7043
Email:
About The "Stock Day" Podcast
Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America. Stock Day recently launched its Video Interview Studio located in Phoenix, Arizona.
SOURCE:
Stock Day Media
602-441-3474
To view the source version of this press release, please visit
